Previous 10 | Next 10 |
HERTFORDSHIRE, England , and PITTSBURGH , Sept. 8, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced an agreement to acquire the related intellectual property and commercialization rights of Aspen Pharmacare Holdings Limited's thrombosis business in Europe ...
Mylan N.V. (NASDAQ: MYL ) and Biocon Biologics India, a subsidiary of Biocon Ltd. ( OTC:BCNQY ) announce the U.S. launch of Semglee (insulin glargine injection) in vial and pre-filled pen to help control high blood sugar in adult and pediatric patients with type 1 diabetes and adults w...
HERTFORDSHIRE, England and PITTSBURGH and BENGALURU, India , Aug. 31, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Biocon Biologics India Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), today announced the U.S. launch of Semglee™ (insulin ...
HERTFORDSHIRE, England and PITTSBURGH , Aug. 28, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the hospital/clinic level of four lots of Amiodarone HCl Injection, U...
Eli Lilly (NYSE: LLY) and Pfizer (NYSE: PFE) are two of several pharma giants in the race to combat COVID-19. Eli Lilly is currently evaluating three potential therapies for the disease in clinical trials, while Pfizer has kicked off a phase 3 study for its lead COVID-19 vaccine candidat...
One of the most common reasons people don't start a stock portfolio is that they think they can't afford to invest. While some stocks may not be attainable buys with a smaller starting amount, you can still build your portfolio with a modest initial investment and set yourself up for healthy fut...
Change Healthcare acquires medical imaging platform Nucleus.io Change Healthcare ( CHNG ) announced that it has acquired Nucleus.io, a leading imaging company. The company looks to augment its medical imaging portfolio with this acquisition. Nucleus.io is believed to have more than 7,500...
Aquestive Therapeutics (NASDAQ: AQST ) initiates a Phase 1 clinical trial in 28 healthy volunteers evaluating the safety and pharmacokinetics (PK) of AQST-108, an oral sublingual formulation of epinephrine, for the potential treatment of allergic reactions, including anaphylaxis (ac...
This article is part of a series that provides an ongoing analysis of the changes made to John Paulson's 13F stock portfolio on a quarterly basis. It is based on Paulson's regulatory 13F Form filed on 08/14/2020. Please visit our Tracking John Paulson's Paulson & Company Portfolio serie...
Mylan N.V. (NASDAQ: MYL ) announces the launch of the first FDA-approved therapeutically equivalent, substitutable generic of Biogen's Tecfidera capsules. More news on: Mylan, Inc., Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc. PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Nov. 6, 2020 HERTFORDSHIRE, England and PITTSBURGH , Nov. 6, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ...
Our experts issued a rare "Double Down" Buy alert on this one stock... Learn more. A long-awaited deal will soon be done. Pfizer (NYSE: PFE) and Mylan (NASDAQ: MYL) announced last week that the U.S. Federal Trade Commission has approved the planned merger of Pfizer's...
Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets for Viatris PR Newswire HERTFORDSHIRE, England, and PITTSBURGH, Nov. 2, 2020 HERTFORDSHIRE , England, and PITTSBURGH, Nov. 2, 2020 /PRNews...